Welcome to the website of Michael Schlander,

Professor of Health Economics at the University of Heidelberg
and
Head of Division of Health Economics at German Cancer Research Center (DKFZ)
Founder and Chairman of InnoVal^HC,
Institute for Innovation & Valuation in Health Care
[member, Stockholm Network of European Think Tanks]

News

2020

10-08-2020 13:42

WZW und HTA: Wie steht es um die Kosten / Nutzenbeurteilung in der Schweiz?

Talk in German available: Michael Schlander presented on the topic "HTA in Switzerland - WZW Criteria" (Wirksamkeit / Efficacy, Zweckmässigkeit / Appropriateness, Wirtschaftlichkeit / Efficiency) at the 6. Swiss Healthcare Day in Bern / Switzerland (January 15, 2020) .